Full text
4/2026
vol. 43
Original paper
Effects of red and blue light therapy combined with paroxetine on anxiety, depression and inflammatory factors in papulopustular rosacea
Department of Dermatology and Venereology, the First People’s Hospital of Shuangliu District (West China Airport Hospital of Sichuan University), Chengdu, China
Department of Stomatology, the First People’s Hospital of Shuangliu District (West China Airport Hospital of Sichuan University), Chengdu, China
Adv Dermatol Allergol 2026; XLIII (4): 396-402
Data publikacji online: 2026/09/14
- Sharma A, Kroumpouzos G, Kassir M, et al. Rosacea management: a comprehensive review. J Cosmetic Dermatol 2022; 21: 1895-904.
- Suarez MV, Francesconi F, Gonçalves H, et al. Epidemiological profile of rosacea in dermatology outpatient clinics in Brazil: an observational report from the Brazilian study group on rosacea. Eur J Dermatol 2023; 33: 6-11.
- Blumenberg M. Skinomics: transcriptional profiling in dermatology and skin biology. Curr Genom 2012; 13: 363-8.
- Sun YH, Man XY, Xuan XY, et al. Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: a retrospective case series. Dermatol Ther 2022; 35: e15848.
- Xu J, Zhang Y, Ci C, et al. Relationship of the specific inflammatory cytokines KLK5, IL-8, and IL-22 with Demodex density and risk factors in rosacea. J Inflamm Res 2025; 18: 15737-48.
- Chen M, Deng Z, Huang Y, Li J. Prevalence and risk factors of anxiety and depression in rosacea patients: a cross-sectional study in China. Front Psychiatry 2021; 12: 659171.
- Sharma K, Kumar S. Current strategies for the management of psoriasis with potential pharmacological pathways using herbals and immuno-biologicals. Curr Mol Pharmacol 2024; 17. DOI: 10.2174/1874467217666230915125613.
- Guo Z, Yuan K. The application of light emitting diode (LED) in cosmetic dermatology. Photodermatol Photoimmunol Photomed 2025; 41: e70041.
- Bleibel L, Soko³owska P, Henrykowska G, et al. Unveiling the anti-inflammatory effects of antidepressants: a systematic review of human studies over the last decade. Pharmaceuticals 2025; 18: 867.
- Volk K, Ulfers A, Yi RC, et al. Treatment management for rosacea: current pharmacological and non-pharmacological options. Exp Rev Clin Pharmacol 2025; 18: 589-605.
- Ablon G. A 7-week, open-label study evaluating the efficacy and safety of 415-nm/633-nm phototherapy for treating mild-to-moderate acne in adolescents and adults. J Clin Aesth Dermatol 2025; 18: 25-32.
- Yuan R, Liao Y, Lu X, et al. Advancing paroxetine treatment in depression: predicting remission and plasma concentration, and validating and updating therapeutic reference ranges. Transl Psychiatry 2025; 15: 321.
- Rabinowitz J, Williams JBW, Hefting N, et al. Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A). J Affect Disord 2023; 325: 429-36.
- Rabinowitz J, Williams JBW, Anderson A, et al. Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D). J Affect Disord 2022; 302: 273-9.
- Bae IH, Kwak JH, Na CH, et al. A comprehensive review of the Acne Grading Scale in 2023. Ann Dermatol 2024; 36: 65-73.
- Diogo MLG, Campos TM, Fonseca ESR, et al. Effect of blue light on acne vulgaris: a systematic review. Sensors 2021; 21: 6943.
- Kuppa SS, Kang JY, Kim JY, et al. Red-light LED therapy promotes wound regeneration by upregulating COL1A1, COL2A1, VEGF and reducing IL-1b for anti-inflammation. Lasers Med Sci 2025; 40: 171.
- Zhao C, Jia X, Dong F, et al. Therapeutic effect of alternating red and blue light irradiation combined with collagen in patients with acne vulgaris and the risk factors of short-term recurrence. Am J Transl Res 2022; 14: 7870-9.
- Heinz MV, Yom-Tov E, Mackin DM, et al. A large-scale observational comparison of antidepressants and their effects. J Psychiatr Res 2024; 178: 219-24.
- Park D, Son Y, Lee D, Kim K. Paroxetine suppresses 27-hydroxycholesterol-induced responses in THP-1 human monocytic cells by regulating the AKT/mTORC1 pathway. Sci Rep 2025; 15: 36797.
- Weeks DL, Crooks E, O'Brien KE, et al. A parallel-group randomized controlled trial of blue light versus red light for improving sleep, fatigue, and cognition following stroke: pilot results and recommendations for further study. Contemp Clin Trials 2024; 147: 107736.
- Deng F, Yang R, Yang Y, et al. Visible light accelerates skin wound healing and alleviates scar formation in mice by adjusting STAT3 signaling. Commun Biol 2024; 7: 1266.
- Kowalska M, Nowaczyk J, Fija³kowski £, Nowaczyk A. Paroxetine-overview of the molecular mechanisms of action. Int J Mol Sci 2021; 22: 1662.
- Ning L, Wang X, Xuan B, et al. Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine. Front Immunol 2023; 14: 1145070.
- Dionisie V, Filip GA, Manea MC, et al. The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies. Inflammopharmacology 2021; 29: 75-90.
- Cheung CT, Lancien U, Corvec S, et al. Pro-inflammatory activity of Cutibacterium acnes phylotype IA1 and extracellular vesicles: an in vitro study. Exp Dermatol 2024; 33: e15150.
- Pocino K, Carnazzo V, Stefanile A, et al. Tumor necrosis factor-alpha: ally and enemy in protean cutaneous sceneries. Int J Mol Sci 2024; 25: 7762.
- Yang S, Jiang Y, Yu X, et al. Polyphyllin I inhibits Propionibacterium acnes-induced IL-8 secretion in HaCaT cells by downregulating the CD36/NOX1/ROS/NLRP3/IL-1b pathway. Evid Based Complement Alternat Med 2021; 2021: 1821220.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
